Ultraviolet absorbance can provide a rapid estimate of peptide or protein concentration when the analyte has a known extinction coefficient and the sample is optically suitable. The familiar calculation is based on the Beer-Lambert relationship between absorbance, path length, concentration, and molar absorptivity.
The measurement is simple. Choosing the right wavelength, coefficient, blank, and concentration basis is where most of the scientific work occurs.
A280 depends on specific residues
Absorbance near 280 nm comes mainly from tryptophan and tyrosine, with smaller contributions from disulfide-bonded cystine and sometimes phenylalanine. A peptide without aromatic residues can have little useful A280 signal.
Sequence-based extinction coefficients can be calculated from residue composition, but they assume a defined chemical form. Oxidation, reduction, conjugation, or an absorbing modification can change the coefficient.
For a short peptide with one aromatic residue, an impurity containing that residue can contribute disproportionately. A280 is not inherently target-specific.
Low-UV measurements trade universality for interference
Peptide bonds absorb strongly at lower wavelengths, often around 205 to 220 nm. This can make low-UV methods useful for peptides lacking aromatic residues.
The same region is crowded with interference from buffers, acids, solvents, and many organic compounds. Small wavelength or baseline errors can have large effects. The extinction response also depends on the peptide's bond and side-chain composition.
A low-UV method should use a sequence-appropriate coefficient or calibration rather than treating all peptides as identical.
Beer-Lambert behavior has a usable range
The relationship is commonly written as:
A = εbc
where A is absorbance, ε is molar absorptivity, b is optical path length, and c is concentration.
At very high absorbance, stray light and detector limitations reduce linearity. At very low absorbance, blank and noise dominate. The report should show that the sample lies within a validated or verified linear range, with dilution where necessary.
Agreement across dilutions is a useful check.
Path length is not always one centimeter
Standard cuvettes often use a one-centimeter path, but microvolume instruments infer concentration through much shorter, automatically selected paths. Plate readers have path lengths determined by well geometry and liquid volume unless corrected.
Path-length calibration becomes part of the result. A concentration calculated as though every format were one centimeter can be wrong by orders of magnitude.
The instrument mode and actual path length should be recorded.
Blank composition must match the sample matrix
The blank should contain the same buffer, counterions, additives, and solvent mixture as the sample, minus analyte. Water is not an adequate blank for a sample dissolved in an absorbing formulation.
If the material itself contributes counterion or residual solvent that is absent from the blank, low-wavelength concentration can be biased. Baseline spectra across a range can reveal sloping backgrounds or unexpected absorbance better than a single-wavelength reading.
Scattering looks like absorbance
Particles, aggregates, bubbles, fingerprints, and scratched cuvettes scatter light. The instrument can record that lost transmitted light as apparent absorbance, inflating concentration.
Scattering often produces a wavelength-dependent baseline extending into regions where the peptide should not absorb. Centrifugation or filtration may clarify the sample but also remove peptide-associated material, so recovery must be considered.
A report should note sample clarity and any pretreatment.
Extinction coefficients need a defined basis
Molar absorptivity produces molar concentration. Converting to mass concentration requires molecular weight. For peptide salts or hydrated material, the chosen molecular weight basis changes the result.
An absorbance measurement of dissolved peptide does not automatically account for undissolved material, water in the original powder, or counterion mass. Reports should state whether concentration is expressed as neutral peptide, salt, total material, or another form.
Empirical coefficients determined from an orthogonal concentration method can improve accuracy, but the reference method's uncertainty carries into the coefficient.
What a defensible report includes
Look for:
- sequence or analyte identity;
- wavelength and spectral bandwidth;
- extinction coefficient and its source;
- molecular-weight and salt basis;
- diluent and matched blank;
- cuvette or microvolume path length;
- absorbance range and dilution factor;
- replicate preparation and reading;
- scattering or baseline assessment;
- comparison with an orthogonal content method where accuracy matters.
Reporting the raw absorbance makes the calculation auditable.
What UV concentration does not show
UV absorbance does not independently distinguish target from absorbing impurities. It does not establish sequence, chromatographic purity, sterility, endotoxin, aggregation, or biological activity.
For pure, well-characterized material, it can estimate concentration efficiently. For an unknown mixture, it measures total absorbance under the chosen assumptions.
Bottom line
UV absorbance is reliable when the peptide contains an appropriate chromophore, the extinction coefficient and path length are known, the matrix is matched, and scattering is controlled. Its precision can be excellent while its specificity remains limited, so the claim should be “concentration by UV under the stated model,” not generic peptide purity.
Sources
- United States Pharmacopeia. General Chapter <857> Ultraviolet-Visible Spectroscopy.
- Pace CN, et al. How to measure and predict the molar absorption coefficient of a protein. Protein Science. 1995.
- Anthis NJ, Clore GM. Sequence-specific determination of protein and peptide concentrations by absorbance at 205 nm. Protein Science. 2013.
- International Council for Harmonisation. Q2(R2): Validation of Analytical Procedures.
- U.S. Food and Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics.
Continue reading
Editorial responsibility and corrections
Published by Serum Research. Sources checked October 1, 2026. This is educational material; no independent scientific, clinical, statistical, analytical, or regulatory review is claimed. Read how we review evidence or send a correction.
For Research Use Only. Not for Human Consumption. This page does not provide instructions for medical use or establish the identity, quality, safety, or equivalence of a catalog material.